Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Parkinson Methylation Profiles

PROVIDER: PRJNA342035 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR4176860.fastq.gz	Fastqsanger.gz
	SRR4176871.fastq.gz	Fastqsanger.gz
	SRR4176872.fastq.gz	Fastqsanger.gz
	SRR4176873.fastq.gz	Fastqsanger.gz
	SRR4176874.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Overexpression of Gadd45b perturbs DNA methylation in mouse dopaminergic neurons

Project description:Age is a major risk factor for neurodegenerative diseases like Parkinson disease, but few studies have explored the contribution of key hallmarks of aging, namely DNA methylation changes and heterochromatin destructuration, in the neurodegenerative process. Here, we investigated the consequences of viral overexpression of Gadd45b, a multifactorial protein involved in DNA demethylation, in the mouse midbrain. Gadd45b overexpression induced global and stable changes in DNA methylation, particularly in introns of genes related to neuronal functions, as well as on LINE-1 transposable elements. This was paralleled by disorganized heterochromatin, increased DNA damage and vulnerability to oxidative stress. LINE-1 de-repression, a potential source of DNA damage, preceded Gadd45b-induced neurodegeneration, whereas prolonged Gadd45b expression deregulated expression of genes related to heterochromatin maintenance, DNA methylation or Parkinson disease. Our data indicates that aging-related alterations contribute to dopaminergic neuron degeneration with potential implications for Parkinson disease.

2021-06-11 | GSE176544 | GEO

Reduced representation bisulfite sequencing (RRBS) of cultured cells derived from Parkinson's disease patient [RRBS-seq]

Project description:High throughput sequencing of MSPI digested, size selected and bisulfite converted genomic DNA from control- and sporadic Parkinson´s disease patient derived fibroblasts (n=15), induced pluripotent stem cells (n=26) and differentiated midbrain neurons (n=10). We were able to sequence more than 400,000 CpGs at ≥5x coverage in all samples. Nonetheless, statistical analysis with RnBeads did not identify major differences on single CpG or promoter methylation level between control- and Parkinson´s disease patient derived cells in any cell type.

2018-10-08 | GSE110718 | GEO

Gene expression profiles of PD fibroblasts treated by SNCA expression-control RNAi.

Project description:We investigated gene expression profiles of Parkinson disease (PD) patient's fibroblasts that were treated by SNCA expression-control RNAi to see adverse effects of the RNAi treatment. The data suggested no significant adverse effects caused by the treatment.

2015-06-08 | GSE64266 | GEO

Transcriptional analysis of whole substantia nigra in Parkinson's disease

Project description:Post mortem tissue was dissected from two groups of age and gender matched groups of Parkinson and Control subjects Published work contains more information on Parkinson and Control groups

2010-03-23 | E-GEOD-20292 | biostudies-arrayexpress

Transcriptional analysis of putamen in Parkinson's disease

2010-03-23 | E-GEOD-20291 | biostudies-arrayexpress

Transcriptional analysis of prefrontal area 9 in Parkinson's disease

2010-02-22 | E-GEOD-20168 | biostudies-arrayexpress

Expression analysis of lymphoblast cells lines in Parkinson's disease

Project description:Genome-wide transcriptome analysis of expression changes in EBV transformed cell lines from the Coriell Cell Repository in Parkinson and Control subjects. 8 Parkinson cell lines versus 8 control cell lines.

2010-02-22 | E-GEOD-20153 | biostudies-arrayexpress

Small RNA profiling from cultured cells and tissues derived from Parkinson's disease patient [small RNA-seq]

Project description:High throughput sequencing of small RNAs (mature miRNA and piRNA/piRNA-like molecules) from control- and sporadic Parkinson´s disease patient derived fibroblasts (n=15), induced pluripotent stem cells (n=26) and differentiated midbrain neurons (n=10). In parallel, cingulate gyrus samples from eight control- and eight Parkinson´s disease patients obtained from the Netherlands Brain Bank were sequenced. We found significant differences between the groups in every cell type and in tissue.

2018-10-08 | GSE110719 | GEO

Investigation in the cannabigerol derivative VCE-003.2 as a disease- modifying agent in a mouse model of experimental synucleinopathy

Project description:Here we explore the striatum transcriptomic effects of alpha-synuclein administration in mice as model of Parkinson´s disease. Moreover, we also explore the neuroprotective effect of cannabonoid-based druga (VCE-003.2) as a potential neuroportective agent in Parkinson´s disease

2024-11-30 | E-MTAB-13768 | biostudies-arrayexpress

Project description:DNA methylation involved in the ganglioside GM1 therapy of Parkinson disease

| PRJNA916115 | ENA